These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11841494)

  • 1. CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease.
    Wood JP; Bieda K; Segni M; Herwig J; Krause M; Usadel KH; Badenhoop K
    Eur J Immunogenet; 2002 Feb; 29(1):73-4. PubMed ID: 11841494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
    Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.
    Thude H; Rosenhahn S; Hunger-Dathe W; Müller UA; Barz D
    Eur J Immunogenet; 2004 Dec; 31(6):245-7. PubMed ID: 15548260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome.
    Meyer G; Donner H; Herwig J; Böhles H; Usadel KH; Badenhoop K
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):335-8. PubMed ID: 11298085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease.
    Rau H; Donner H; Usadel KH; Badenhoop K
    Tissue Antigens; 1997 May; 49(5):535-6. PubMed ID: 9174153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.
    Hennig BJ; Fry AE; Hirai K; Tahara H; Tamori A; Moller M; Hopkin J; Hill AV; Bodmer W; Beverley P; Tchilian E
    Tissue Antigens; 2008 May; 71(5):458-63. PubMed ID: 18312479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical distribution and disease associations of the CD45 exon 6 138G variant.
    Ward V; Hennig BJ; Hirai K; Tahara H; Tamori A; Dawes R; Saito M; Bangham C; Stephens H; Goldfeld AE; Kunachiwa W; Leetrakool N; Hopkin J; Dunstan S; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    Immunogenetics; 2006 Apr; 58(2-3):235-9. PubMed ID: 16538473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease.
    Kaczur V; Takács M; Szalai C; Falus A; Nagy Z; Berencsi G; Balázs C
    Eur J Immunogenet; 2000 Feb; 27(1):17-23. PubMed ID: 10651846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PVU II polymorphism of LST-1 (leucocyte specific transcript-1) in type I diabetes mellitus, Graves' disease and healthy controls.
    Rau H; Usadel KH; Ommert S; Badenhoop K
    Eur J Immunogenet; 1995 Jun; 22(3):277-82. PubMed ID: 8547234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
    Badenhoop K; Walfish PG; Rau H; Fischer S; Nicolay A; Bogner U; Schleusener H; Usadel KH
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2112-7. PubMed ID: 7608264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection.
    Tchilian EZ; Wallace DL; Dawes R; Imami N; Burton C; Gotch F; Beverley PC
    AIDS; 2001 Sep; 15(14):1892-4. PubMed ID: 11579257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome.
    Suzuki H; Isaka M; Suzuki S
    Intern Med; 2008; 47(13):1241-4. PubMed ID: 18591848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
    Kallmann BA; Hüther M; Tubes M; Feldkamp J; Bertrams J; Gries FA; Lampeter EF; Kolb H
    Diabetes; 1997 Feb; 46(2):237-43. PubMed ID: 9000700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura subsequent to Graves' disease and insulin-dependent diabetes mellitus.
    Yamaguchi K; Ookubo Y; Matsuda H; Suzaki K; Fukushima H; Uzawa H
    Diabetes Res Clin Pract; 1987; 3(4):233-7. PubMed ID: 3622224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis.
    Pani MA; Regulla K; Segni M; Hofmann S; Hüfner M; Pasquino AM; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2564-7. PubMed ID: 12050214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus.
    Pani MA; Regulla K; Segni M; Krause M; Hofmann S; Hufner M; Herwig J; Pasquino AM; Usadel KH; Badenhoop K
    Eur J Endocrinol; 2002 Jun; 146(6):777-81. PubMed ID: 12039697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.